{
    "nct_id": "NCT04684602",
    "title": "Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions",
    "status": "RECRUITING",
    "last_update_time": "2022-04-27",
    "description_brief": "This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.",
    "description_detailed": "This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.\n\nThis study investigates clinical outcomes of treatments for numerous indications including: Autoimmune, Cardiovascular, Diabetes, Integumentary, Neurologic / Neurodegenerative, Pulmonary, Orthopedic Diseases, Sexual Dysfunction, Urologic Disorders and Viral Illnesses.\n\nOur hypotheses posit that regenerative treatments are both safe and statistically beneficial for a range of conditions. Outcomes will be determined by multiple valid outcome instruments that measure general quality of life information along with condition-specific information.",
    "phase": [
        "PHASE1",
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": null,
    "target_category": "N/A",
    "drug": [
        "Mesenchymal stem cells (regenerative stem cell therapy)"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The trial title and description state this is a multi-arm study of regenerative/stem cell therapy (mesenchymal stem cells) for a wide range of acute and chronic conditions, including neurologic/neurodegenerative indications, but it is not described as targeting Alzheimer-specific pathology (e.g., amyloid or tau). \ue200cite\ue202turn0search2\ue202turn0search0\ue201",
        "Act: Key extracted details \u2014 official title: \"Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions\" (NCT04684602). Intervention described is mesenchymal stem cell / regenerative therapy used across multiple indications (autoimmune, cardiovascular, diabetes, integumentary, neurologic/neurodegenerative, pulmonary, orthopedic, etc.). This identifies the intervention as a biologic (stem cells/MSCs) but not a disease-targeted biologic aimed specifically at Alzheimer\u2019s pathology. \ue200cite\ue202turn0search2\ue202turn0search6\ue201",
        "Additional supporting context: Mesenchymal/stem cell therapies are classified as biologic regenerative-cell interventions and have been tested across conditions (examples of MSC trials in neurologic and other indications are documented in the literature). This supports the identification of the intervention type as a biologic. \ue200cite\ue202turn0search10\ue202turn0search1\ue201",
        "Reflect: Matching to the defined categories \u2014 (1) Disease-targeted biologic: specifically refers to biologics that target Alzheimer pathology (amyloid/tau). Although this trial uses a biologic (stem cells), it is not aimed specifically at Alzheimer disease mechanisms. (2) Disease-targeted small molecule: not applicable. (3) Cognitive enhancer: not described as a cognitive-specific symptomatic enhancer. (4) Neuropsychiatric symptom improvement: not described as targeting behavioral/psychiatric symptoms. Therefore the correct category for this trial (relative to the Alzheimer-focused taxonomy provided) is 'N/A'.",
        "Web search results used (key sources cited above): - ClinicalTrials.gov / TrialsToday listing for NCT04684602 describing the study and title. \ue200cite\ue202turn0search2\ue201 - CenterWatch trial listing summarizing the multi-arm MSC study. \ue200cite\ue202turn0search0\ue201 - UnityTrials summary of the same MSC trial. \ue200cite\ue202turn0search6\ue201 - Example MSC regenerative-cell trials/publications showing MSCs used in neurologic and other indications (TREASURE / MESEMS examples). \ue200cite\ue202turn0search10\ue202turn0search1\ue201"
    ],
    "agent_type": "N/A",
    "explanation_agent": []
}